Will collagen help hair loss? It's a question increasingly asked as collagen supplements flood the UK market, promising thicker, healthier hair. Collagen is the body's most abundant structural protein, playing a key role in the extracellular matrix surrounding hair follicles — and its natural decline with age has fuelled interest in supplementation. However, the scientific evidence linking collagen supplements directly to hair regrowth remains limited and preliminary. This article examines what collagen actually does, what the research shows, which types of hair loss it may or may not address, and what clinically supported treatments are available through the NHS.

What Is Collagen and How Does It Relate to Hair Growth?

Collagen forms the extracellular matrix surrounding hair follicles and supports the dermal papilla, but it does not directly drive keratin synthesis, as hair relies on sulphur-rich amino acids that collagen lacks.

Collagen is the most abundant structural protein in the human body, accounting for roughly 30% of total protein content. It provides tensile strength and elasticity to skin, tendons, cartilage, and connective tissues. There are at least 28 known types of collagen, though Types I, II, and III are the most prevalent. In the context of hair, Type I and Type III collagen are particularly relevant, as they form part of the extracellular matrix (ECM) surrounding hair follicles.

The hair follicle is embedded within the dermis, a layer of skin rich in collagen fibres. The collagen-containing ECM of the dermal sheath supports the structural environment around the follicle, while the dermal papilla — a specialised cluster of mesenchymal cells within this matrix — plays a critical role in regulating the hair growth cycle. This cycle consists of three phases: anagen (growth), catagen (transition), and telogen (rest). Maintaining the integrity of the follicular ECM is thought to support the microenvironment necessary for healthy hair production.

Collagen contains high concentrations of the amino acids glycine, proline, and hydroxyproline. It is important to note, however, that hair keratin is primarily sulphur-rich, relying on amino acids such as cysteine and methionine — which collagen does not provide in meaningful quantities. Collagen's amino acids therefore do not directly drive keratin synthesis in the way that some supplement marketing implies. What matters more broadly is adequate overall dietary protein, including sufficient sulphur-containing amino acids from a varied diet.

Some collagen peptides have demonstrated antioxidant properties in laboratory (in vitro) and animal studies, which has led to speculation that they may help protect follicle cells from oxidative damage. However, these effects have not been reliably demonstrated in human hair studies, and no clinical conclusions can be drawn from this mechanism alone.

As we age, natural collagen production declines — typically from the mid-20s onwards — which contributes to changes in skin elasticity and the follicular ECM. This biological relationship has led to growing interest in whether supplementing collagen could meaningfully support hair health, though the evidence remains limited (see next section).

Evidence Behind Collagen Supplements for Hair Loss

Evidence for collagen supplements in hair loss is preliminary and limited; no UK regulatory body has approved them for this use, and existing trials are small, short-term, and often industry-funded.

Not sure if this is normal? Chat with one of our pharmacists →

The scientific evidence supporting collagen supplements specifically for hair loss remains limited and, in many cases, preliminary. Most available studies focus on skin elasticity and hydration rather than hair regrowth directly. A small number of clinical trials have examined the effect of hydrolysed collagen peptides — a broken-down, more bioavailable form of collagen — on hair thickness, growth rate, and scalp condition, but significant methodological limitations apply across this body of research.

One double-blind, placebo-controlled study (Proksch et al., Journal of Cosmetic Dermatology, 2014, and related industry-sponsored trials) reported improvements in hair-related outcomes in women taking specific collagen peptide supplements over 12–16 weeks. However, several of these products contained additional vitamins and minerals alongside collagen, making it impossible to attribute any observed benefit to collagen alone. Sample sizes were small, follow-up periods were short, and most studies were industry-funded — all of which limit the strength of conclusions. A 2021 narrative review noted that marine collagen peptides may support keratin-associated protein synthesis and potentially influence hair shaft parameters, but the authors acknowledged that larger, independent, and well-controlled trials are needed before any firm recommendations can be made.

It is important to note that no regulatory body — including the MHRA, NICE, or the EMA — has approved collagen supplements as a treatment for hair loss. The evidence base does not yet meet the threshold required for clinical recommendation. No standardised dose or specific collagen product can be recommended on the basis of current evidence. Key limitations across existing studies include:

• Small participant numbers

• Short follow-up periods

• Use of multi-ingredient products that confound attribution

• Lack of standardised dosing protocols

• Potential conflicts of interest from industry sponsorship

While the theoretical mechanisms are biologically plausible, patients should approach marketing claims with caution. Collagen supplements may offer modest supportive benefits for some individuals, but they should not be considered a primary or proven treatment for clinically significant hair loss.

Types of Hair Loss and Whether Collagen May Help

Collagen is unlikely to address the hormonal drivers of androgenetic alopecia or immune-mediated alopecia areata; it has the most theoretical relevance in age-related thinning, though even here evidence is weak.

Hair loss is not a single condition — it encompasses a wide range of causes, each with distinct mechanisms and treatment pathways. Understanding the type of hair loss is essential before considering any intervention, including collagen supplementation. A GP assessment should always be the first step.

Androgenetic alopecia (male- and female-pattern hair loss) is the most common form, driven by genetic sensitivity to dihydrotestosterone (DHT). Collagen is unlikely to address the hormonal and genetic drivers of this condition, though it may theoretically support the broader follicular environment to a modest degree.

Telogen effluvium is a diffuse shedding triggered by physiological stress, nutritional deficiency, illness, or hormonal changes such as postpartum shifts. Because this type of hair loss is often linked to nutritional depletion, ensuring adequate overall dietary protein — including sulphur-containing amino acids from sources such as eggs, meat, fish, legumes, and dairy — is important. Collagen supplements are not superior to a balanced, protein-sufficient diet for this purpose and should not be used as a substitute for addressing underlying nutritional deficiencies.

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles. There is no evidence that collagen supplements influence immune-mediated hair loss, and this condition requires medical assessment and management.

Traction alopecia and scarring alopecias are caused by physical damage or fibrosis of the follicle, respectively. Collagen supplementation is unlikely to reverse structural follicle damage in these cases.

In summary, collagen may have the most theoretical relevance in cases of age-related hair thinning where the follicular ECM may be suboptimal, but even here the evidence is weak. For all types of hair loss, a confirmed diagnosis from a GP or dermatologist is essential before pursuing any supplement-based approach.

Seek prompt GP assessment if you notice any of the following:

• Sudden or rapidly worsening hair loss

• Patchy or irregular bald areas

• Scalp redness, scaling, pustules, pain, or scarring

• Broken hairs or scalp scale in a child (which may suggest tinea capitis)

• Loss of eyebrows or eyelashes

• Hair loss accompanied by systemic symptoms (fatigue, weight change, joint pain)

• Signs of hyperandrogenism in women (acne, hirsutism, irregular periods)

Referral to an NHS dermatologist may be appropriate for uncertain diagnoses, scarring alopecias, or treatment-resistant cases. The NHS Hair loss page and NICE Clinical Knowledge Summaries (CKS) for male-pattern hair loss and alopecia areata provide further guidance on assessment and referral pathways.

How to Use Collagen Supplements Safely in the UK

Choose hydrolysed collagen peptides at 2.5–10 g daily, check for allergens and third-party testing, and allow at least 12–16 weeks before assessing results; consult a GP if pregnant or on prescribed medication.

In the UK, collagen supplements are classified as food supplements rather than medicines. They are regulated under the Food Supplements (England) Regulations 2003 (and equivalent devolved legislation), with oversight from the Food Standards Agency (FSA) and the Office for Product Safety and Standards (OPSS). Unlike licensed medicines, food supplements do not require clinical trial evidence before being placed on the market. Under the ASA/CAP Code, manufacturers are prohibited from making specific medicinal claims — for example, stating that a product treats or prevents hair loss. Consumers should be aware of this distinction when evaluating product labelling and advertising.

If you choose to try a collagen supplement, the following practical guidance applies:

• Choose hydrolysed collagen peptides, as these are broken down into smaller molecules and are more readily absorbed by the body than intact (native) collagen.

• Marine collagen (derived from fish) and bovine collagen (from cattle) are the most commonly studied forms. Some studies suggest marine collagen may have favourable absorption characteristics, but head-to-head human data comparing bioavailability between sources are limited and product-dependent; no definitive superiority can be claimed.

• 'Vegan collagen' products are typically collagen precursor or booster formulations (containing vitamin C, amino acids, or plant extracts) rather than collagen itself; their effects on hair have not been studied.

• Typical doses used in studies range from 2.5 g to 10 g per day, though no standardised therapeutic dose has been established for hair loss specifically.

• Allow adequate time — most studies run for at least 12–16 weeks before assessing outcomes. Do not expect rapid results.

• Check the label carefully for: source species and collagen type, daily amount per serving, allergen declarations, batch or lot number, and UK Food Business Operator (FBO) contact details. Products that have undergone independent third-party testing for purity and contaminants offer an additional level of assurance.

• Check for allergens — marine collagen is unsuitable for individuals with fish allergies; bovine collagen may not be appropriate for those with certain dietary or religious restrictions.

Collagen supplements are generally considered safe for most adults. Reported side effects are uncommon but may include mild digestive discomfort such as bloating or a feeling of fullness. If you are pregnant, breastfeeding, or taking prescribed medication, consult your GP or pharmacist before starting any new supplement.

Experiencing these side effects? Our pharmacists can help you navigate them →

If you experience a suspected adverse reaction to a food supplement or medicine, you can report it to the MHRA via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.

Other Clinically Supported Treatments for Hair Loss

Topical minoxidil (OTC) and prescription finasteride (men) are the most evidence-based treatments for androgenetic alopecia in the UK; nutritional deficiencies in iron, vitamin D, and zinc should also be investigated by a GP.

For individuals experiencing significant or progressive hair loss, it is important to be aware of treatments with a stronger evidence base and regulatory approval. NICE and NHS guidance outlines several clinically validated options depending on the underlying cause.

Minoxidil (topical) is available over the counter in the UK as a solution or foam and is licensed for androgenetic alopecia in both men and women. It works by prolonging the anagen phase of the hair cycle and increasing follicular size. Results typically become apparent after three to six months of consistent use. Common side effects include scalp irritation, contact dermatitis, and a temporary increase in shedding during the first few weeks of use. Topical minoxidil should be avoided during pregnancy and breastfeeding unless specifically advised by a clinician. Full prescribing information is available on the electronic Medicines Compendium (emc).

Minoxidil (oral, low-dose) is also used for hair loss but is prescribed off-label in the UK. It should only be initiated and monitored by a clinician experienced in its use. Risks include hypotension, peripheral oedema, tachycardia, and hypertrichosis (unwanted hair growth elsewhere on the body). It is not suitable for self-purchase or unsupervised use.

Finasteride (1 mg daily) is a prescription-only medicine licensed in the UK for male-pattern hair loss. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing DHT levels at the follicle. It is not licensed for use in women of childbearing potential due to the risk of harm to a male foetus. Important MHRA safety information includes: potential sexual side effects (reduced libido, erectile dysfunction, ejaculatory disorders) and psychiatric effects including depression and, rarely, suicidal ideation — patients should be counselled about these risks before starting treatment and given a patient alert card. Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets. Patients taking finasteride are advised not to donate blood during treatment and for one month after stopping. Full safety information is available in the MHRA Drug Safety Update and on the emc.

Corticosteroids — administered topically, by intralesional injection, or systemically — are used in the management of alopecia areata and certain inflammatory scalp conditions, under dermatological supervision.

Immunomodulatory treatments: For moderate-to-severe alopecia areata, NHS dermatologists may consider JAK inhibitors such as baricitinib, subject to NICE guidance, licensing, and local commissioning decisions. This is a specialist area and not suitable for self-referral or self-treatment.

Nutritional optimisation is an important and often overlooked component of hair health. Deficiencies in iron, ferritin, vitamin D, zinc, and B vitamins are associated with hair shedding. A GP can arrange appropriate blood tests (which may include full blood count, ferritin, thyroid function, and vitamin D, depending on clinical presentation) to identify and address these deficiencies. Biotin (vitamin B7) deficiency is uncommon in people eating a varied diet; supplementing with high-dose biotin without clinical indication is not recommended, as it can interfere with a range of laboratory assays (including thyroid function tests and troponin assays) and produce misleading results.

If hair loss is sudden, patchy, associated with scalp symptoms, or causing significant distress, contact your GP promptly. Referral to an NHS dermatologist is appropriate for uncertain diagnoses, scarring alopecias, or cases that do not respond to first-line treatment. Trichologists are not statutorily regulated healthcare professionals and are not part of standard NHS referral pathways; an NHS dermatologist is the appropriate specialist for complex or uncertain hair loss.

Collagen supplements may complement a broader hair health strategy for some individuals, but they should not replace evidence-based medical assessment and treatment.

Frequently Asked Questions